Additional non-GAAP financial measures, including net revenue excluding the Lookback Adjustments, Adjusted EBITDA excluding the Lookback Adjustments, net revenue excluding both the Non-Encompass BPO services revenue and the Lookback Adjustments and Adjusted EBITDA excluding both the Non-Encompass BPO services gross margin and the Lookback Adjustments, are also included in this Press Release. The Lookback Adjustments are revenue adjustments that represent changes in estimates relating to performance obligati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 214 West Huron St. Chicago, Illinois 60654 (Address of principal executive offices) (Zip Code) (312) 386-8200 (Registrant's telephone number, including area code) For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro ...

GoHealth, Inc. (NASDAQ:GOCO) Q2 2023 Earnings Conference Call August 10, 2023 8:00 AM ET Company Participants John Shave - VP, IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day and thank you for standing by. Welcome to the GoHealth Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. P ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (State ...

GoHealth, Inc. (NASDAQ:GOCO) Q1 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants John Shave - VP of IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Mike Cherny - Bank of America Jonathan Yong - Credit Suisse Ben Hendrix - RBC Capital Markets Operator Good morning, and welcome to the GoHealth First Quarter 2023 Earnings Conference Call. My name is Michelle, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Fol ...

FORWARD-LOOKING STATEMENTS 2 In these slides, we use supplemental measures of our performance that are derived from our consolidated financial information, but which are not presented in our Consolidated Financial Statements prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures include net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization expense, or EBITDA, Adjusted EBITDA and Adjusted EBITDA margin ...

Medicare Market Growth - The current commissionable market for health insurance is nearly $30 billion, with over 10,000 Americans turning 65 every day, indicating a strong growth opportunity in the Medicare space[27]. - Medicare enrollment is projected to grow from approximately 63 million individuals in 2021 to about 93 million by 2060, representing a significant increase in the addressable market[41]. - In 2022, 48% of Medicare beneficiaries, approximately 28.4 million people, were enrolled in Medicare Advantage plans, an increase of about 2.2 million from 2021[42]. Revenue Sources and Partnerships - The Medicare—Internal segment is the largest revenue contributor, with a focus on multi-health plan partner channels and qualified prospect placements[36]. - Health plans owned by Humana, Elevance, United, and Centene accounted for approximately 26%, 23%, 18%, and 11% of net revenues respectively for the twelve months ended December 31, 2022[49]. - GoHealth relies on a small group of health plan partners for revenue, with Humana, Elevance, United, and Centene accounting for approximately 26%, 23%, 18%, and 11% of net revenues for the twelve months ended December 31, 2022[113]. Technology and Consumer Engagement - The company has invested significantly in technology and data science to enhance consumer engagement and improve the efficiency of the health insurance enrollment process[28]. - The proprietary LeadScore technology predicts the lifetime value and conversion probability of consumer leads, optimizing the routing of leads in real-time[36]. - GoHealth utilizes a proprietary LeadScore technology that predicts the expected lifetime value (LTV) of incoming consumer leads based on historical data, optimizing the sales process[52]. - The company has developed a SPLICE system for contact queuing, prioritizing outreach to valuable consumer leads based on LTV and agent capacity, resulting in minimal wait times for consumers[52]. - GoHealth's Marketplace technology allows agents to compare health plans available to consumers in their geography, enhancing the decision-making process for consumers[54]. - The company employs a data-driven, omnichannel marketing strategy, including offline media (TV and radio) and digital media (paid search and social media), to drive consumer engagement[57]. Compliance and Regulatory Challenges - The company is subject to extensive regulations, including compliance with the Telephone Consumer Protection Act (TCPA) and various state and federal privacy laws, impacting its marketing and operational strategies[57][65]. - The company faces risks related to compliance with complex and frequently changing laws and regulations governing Medicare plans[76]. - Regulatory changes could limit the compensation received from health plan partners, adversely affecting GoHealth's financial results[118]. - The company must maintain valid licenses in all 50 states, which imposes significant operational costs and complexity[139]. - The company is subject to numerous privacy and data protection laws, which may impose restrictions on processing personal information and could lead to enforcement actions if not complied with[150]. Financial Performance and Risks - The company has identified a material weakness in internal controls over financial reporting, which could lead to errors in financial statements[101]. - The company’s revenue growth is highly dependent on attracting new beneficiaries during the Medicare annual enrollment period[98]. - The company’s commission rates from health plan partners can be altered with short notice, impacting revenue stability[99]. - The company faces significant upfront expenses for customer enrollment, which impacts cash flow as commissions are received over time[145]. - The company may not be able to generate sufficient cash flow from operations to repay its indebtedness when it becomes due[192]. Workforce and Employee Dynamics - As of December 31, 2022, the company employed 2,467 employees, with 2,363 in the United States and 104 in Slovakia[69]. - Approximately 52% of the global workforce and 42% of managerial roles identified as female as of December 31, 2022[71]. - The company faces challenges in attracting and retaining qualified employees due to a competitive labor market, which may require offering higher compensation[112]. Market Competition and Strategy - The competitive landscape for health insurance plans is intensifying, with pressure from both existing and new competitors potentially harming the company's business and financial condition[129]. - The company competes with government-run health insurance exchanges, which could increase marketing costs and reduce revenue[132]. - Increased competition for referrals from third-party lead referral companies could harm the company's business and financial condition if competitors pay higher fees[149]. Internal Controls and Governance - The company expects to incur costs related to implementing an internal audit and compliance function in the upcoming years to improve its internal control environment[223]. - The company is required to document and test its internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, which may require significant changes to its internal controls[222]. - The company qualifies as a "controlled company" under Nasdaq rules, relying on exemptions from certain corporate governance requirements[208].

GoHealth, Inc. (NASDAQ:GOCO) Q4 2022 Earnings Conference Call March 16, 2023 5:00 PM ET Company Participants John Shave - VP, IR Vijay Kotte - Chief Executive Officer Jason Schulz - Chief Financial Officer Conference Call Participants Michael Cherny - Bank of America Jonathan Yong - Credit Suisse Ben Hendrix - RBC Capital Markets Adam Klauber - William Blair Operator Good afternoon, and welcome to the GoHealth Fourth Quarter and Full Year 2022 Earnings Conference Call. My name is Lisa, and I will be your op ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (St ...

Financial Data and Key Metrics Changes - Cash flow from operations improved significantly from a loss of $40 million in Q3 2021 to a positive $96 million in Q3 2022, marking a $136 million improvement [9][42] - Revenue for Q3 2022 was $133 million, down from $212 million year-over-year, reflecting a strategic focus on higher-quality revenue [10][38] - Adjusted EBITDA was approximately flat compared to the previous year despite a $79 million decline in revenue, indicating improved operational efficiency [10][40] Business Line Data and Key Metrics Changes - Commission revenue decreased by 50% year-over-year to $87 million, attributed to a reduction in the number of agents to enhance quality [39] - Enterprise revenue increased by 25% year-over-year to $46 million, driven by the Encompass business generating $9 million in revenue [39] Market Data and Key Metrics Changes - The company reported a 20% improvement in retention and a 10% reduction in complaints to Medicare, indicating positive market reception of the Encompass solution [22] Company Strategy and Development Direction - The company is transitioning from a transactional e-broker model to a trusted consumer marketplace, focusing on quality and relationships with beneficiaries [7][15] - Encompass is positioned as a critical component of the strategy, expected to enhance customer service and financial performance [15][33] - The company anticipates a shift towards a more predictable revenue model with Encompass Connect, reducing exposure to the volatility of the traditional LTV model [25][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving cash flow breakeven on a trailing 12-month basis in early 2023, supported by the early success of strategic initiatives [45] - The company plans to effectuate a reverse stock split to benefit stakeholders, indicating a proactive approach to financial management [30] Other Important Information - The company received a $50 million strategic investment from significant partners to enhance customer service and market value [14] - The company ended the quarter with $250 million in cash, a significant increase from $84 million at year-end, driven by Encompass cash collections [43] Q&A Session Summary Question: Deferred revenue dynamics and future expectations - Management indicated that the increase in deferred revenue is related to the Encompass arrangement and will fluctuate with business volume throughout the year [48][49] Question: Interaction with seniors and go-forward strategy - Management explained that the Encompass model provides a different experience for beneficiaries, emphasizing quality relationships and improved technology tools for better plan matching [50][53]